Availability and future perspectives of psychopharmaceuticals in the Czech-Slovak context: what is and isn't available, and what could be
Psychiatrie pro praxi · 21.07.2026 · 27 (2) · 94-98
DOI: 10.36290/psy.2026.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatrie pro praxi, erschienen am 21.07.2026. Verfasst von Štefan Artim. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Psychofarmaka jsou spolen s psychoterapi zkladnm prostedkem v lb duevnch poruch. Jejich dostupnost je rzn a multifaktoriln podmnn, piem roli hraje legislativa, velikost trhu a mstn specifika. V tomto pehledovm lnku pedkldme shrnut dostupnosti rznch psychofarmak v eskm a slovenskm prosted. Navzdory socioekonomick blzkosti krajin jsou rozdly msty zsadn. Dal st se vnuje skupinm novjch liv, kter jsou v rznm stupni schvalovn, avak v naem regionu dosud nejsou dostupn, ppadn zatm zstvaj ve fzi klinickch studi. Zajmavm trendem v oboru mohou bt nap. tzv. fixn kombinace liv (FDC), melatoninov agonist, neurosteroidy, inhibitory VMAT2 a nejnovj molekuly uren k lb farmakorezistentn schizofrenie.
Zitieren
APA
Artim, Š. (2026). Availability and future perspectives of psychopharmaceuticals in the Czech-Slovak context: what is and isn't available, and what could be. Psychiatrie pro praxi, 27(2), 94-98. https://doi.org/10.36290/psy.2026.016
Vancouver
Artim Š. Availability and future perspectives of psychopharmaceuticals in the Czech-Slovak context: what is and isn't available, and what could be. Psychiatrie pro praxi. 2026;27(2):94-98. doi:10.36290/psy.2026.016
BibTeX
@article{Artim2026,
author = {Artim, Štefan},
title = {Availability and future perspectives of psychopharmaceuticals in the Czech-Slovak context: what is and isn't available, and what could be},
journal = {Psychiatrie pro praxi},
year = {2026},
volume = {27},
number = {2},
pages = {94--98},
doi = {10.36290/psy.2026.016}
}
EUVIMED